Sanuwave Q2 2026 revenue tops revised guidance range
Go back to Sanuwave Q2 2026 revenue tops revised guidance range| SANUWAVE Health, Inc. (NASDAQ: SNWV) | Delayed: 5.05 +0.02 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.03 | 52 Week High | $0.20 | |||
| Open | $5.03 | 52 Week Low | $0.03 | |||
| Day High | $5.19 | P/E | N/A | |||
| Day Low | $4.90 | EPS | $-0.50 | |||
| Volume | 79,121 | |||||
